Julio Font
Algemeen Directeur bij Noray Bioinformatics SL
Actieve functies van Julio Font
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Noray Bioinformatics SL
 Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Algemeen Directeur | 21-10-2002 | - |
| Oprichter | 21-10-2002 | - | |
Histocell SL
 Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Algemeen Directeur | - | - |
Loopbaan van Julio Font
Statistieken
Internationaal
| Spanje | 3 |
Operationeel
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectoraal
| Technology Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Noray Bioinformatics SL
Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Technology Services |
Histocell SL
Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Health Technology |
- Beurs
- Insiders
- Julio Font
- Ervaring
